The effects of antifungal chemoprophylaxis and empiric therapy on invasive fungal infection in neutropenic children with malignant neoplasms

• Published in: Pediatric hematology and oncology Vol. 12; no. 1; p. 1
• Main Authors: Kato, Y, Hoshi, Y, Akatsuka, J, Suzuki, M
• Format: Journal Article
• Language: English
• Published: England 01.01.1995
• Subjects: Amphotericin B - therapeutic use; Antifungal Agents - therapeutic use; Child; Humans; Mycoses - prevention & control; Neoplasms - complications; Neoplasms - drug therapy; Neutropenia - complications
• ISSN: 0888-0018
• DOI: 10.3109/08880019509029523

Since January 1987, chemoprophylaxis and empiric therapy with antifungal drugs have been used routinely in neutropenic children with neoplasms. The incidence of terminal invasive fungal infection (IFI) diagnosed by autopsy findings is compared in two groups: group A, consisting of 25 patients autopsied between January 1982 and December 1986, and group B, consisting of 14 patients autopsied between January 1987 and December 1991. There was no difference in the incidence of IFI between the two groups, but the characteristics of IFI appeared to differ. With the recent intensification of chemotherapy, the patients in group B had more risk factors for IFI. It might therefore have been anticipated that group B patients may have shown an increase in IFI. No such increase was observed, suggesting that the prophylaxis was effective. Autopsy findings also showed that the target organs of IFI were localized and that systemic candidiasis was decreased in group B. It is thus concluded that the present antifungal countermeasures are effective, although some problems still remain.